After UK adverse event, Serum Institute halts India trials of Oxford vaccine candidate
SEPTEMBER 10, 2020 4:45:50 PM
The trials were halted by AstraZeneca after one participant, who reportedly took part in the phase 2/3 clinical trials underway in the United Kingdom, developed a "potentially unexplained illness".
.png)
No hay comentarios:
Publicar un comentario